Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$44.2 - $50.2 $19 Million - $21.6 Million
430,217 New
430,217 $19.6 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $57.1 Million - $93.3 Million
1,257,003 New
1,257,003 $82.6 Million
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $28.6 Million - $44.7 Million
-395,274 Reduced 81.71%
88,460 $6.4 Million
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $18.1 Million - $23.6 Million
207,277 Added 74.98%
483,734 $51.9 Million
Q1 2022

May 16, 2022

SELL
$94.19 - $124.49 $18 Million - $23.8 Million
-191,273 Reduced 40.89%
276,457 $30.7 Million
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $10.2 Million - $11.8 Million
85,030 Added 22.22%
467,730 $59.9 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $41.1 Million - $53.6 Million
376,246 Added 5829.66%
382,700 $50.9 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $647,594 - $746,663
6,454 New
6,454 $698,000
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $3 Million - $4.93 Million
-62,391 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $2.31 Million - $3.93 Million
62,391 New
62,391 $3.24 Million
Q4 2017

Feb 14, 2018

SELL
$37.27 - $43.02 $2.95 Million - $3.4 Million
-79,143 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $2.67 Million - $3.3 Million
79,143
79,143 $3.16 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.7B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.